Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%

ClinicalTrials.gov ID: NCT01456611

Public ClinicalTrials.gov record NCT01456611. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 9:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Evaluate the Clinical Equivalence of Diclofenac Sodium 1% Gel (Anchen Pharmaceuticals, Inc.) With Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis) in Patients With Osteoarthritis of the Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to evaluate the clinical equivalence and safety of the Test formulation of diclofenac sodium topical gel 1% (Anchen Pharmaceuticals, Inc.) compared to the marketed formulation Voltaren® Gel (diclofenac sodium topical gel) 1% (Novartis) in patients with osteoarthritis of the knee. The efficacy of both the Test and Reference formulations will also be compared to the Placebo gel to determine Superiority.

Study identification

NCT ID
NCT01456611
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Anchen Pharmaceuticals, Inc
Industry
Enrollment
749 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
35 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2011
Primary completion
Mar 31, 2012
Completion
Mar 31, 2012
Last update posted
Jul 11, 2012

2011 – 2012

United States locations

U.S. sites
57
U.S. states
20
U.S. cities
57
Facility City State ZIP Site status
Novum Investigator Site Birmingham Alabama
Novum Investigator Site Huntsville Alabama
Novum Investigator Site Chandler Arizona
Novum Investigator Site Mesa Arizona
Novum Investigator Site Phoenix Arizona
Novum Investigator Site Tuscon Arizona
Novum Investigator Site Little Rock Arkansas
Novum Investigator Site Anaheim California
Novum Investigator Site Carmichael California
Novum Investigator Site Garden Grove California
Novum Investigator Site Long Beach California
Novum Investigator Site Sacramento California
Novum Investigator Site San Diego California
Novum Investigator Site Stock Bridge California
Novum Investigator Site Denver Colorado
Novum Investigator Site Norwalk Connecticut
Novum Investigator Site Stamford Connecticut
Novum Investigator Site Adventura Florida
Novum Investigator Site Bookville Florida
Novum Investigator Site Bradenton Florida
Novum Investigator Site Daytona Beach Florida
Novum Investigator Site Hialeah Florida
Novum Investigator Site Jupiter Florida
Novum Investigator Site Miami Florida
Novum Investigator Site Ormond Beach Florida
Novum Investigator Site Pinellas Park Florida
Novum Investigator Site Sarasota Florida
Novum Investigator Site St. Petersburg Florida
Novum Investigator Site Tampa Florida
Novum Investigator Site Marietta Georgia
Novum Investigator Site Sandy Springs Georgia
Novum Investigator Site Lexington Kentucky
Novum Investigator Site New Orleans1 Louisiana
Novum Investigator Site Hollywood Maryland
Novum Investigator Site Billings Montana
Novum Investigator Site Henderson Nevada
Novum Investigator Site Cary North Carolina
Novum Investigator Site Charlotte North Carolina
Novum Investigator Site Hickory North Carolina
Novum Investigator Site High Point North Carolina
Novum Investigator Site Raleigh North Carolina
Novum Investigator Site Salisbury North Carolina
Novum Investigator Site Wilmington North Carolina
Novum Investigator Site Winston-Salem North Carolina
Novum Investigator Site Cleveland Ohio
Novum Investigator Site Columbus Ohio
Novum Investigator Site Beavercreek Oklahoma
Novum Investigator Site Norman Oklahoma
Novum Investigator Site Duncansville Pennsylvania
Novum Investigator Site Chattanooga Tennessee
Novum Investigator Site Houston Texas
Novum Investigator Site Longview Texas
Novum Investigator Site San Antonio Texas
Novum Investigator Site Sugar Land Texas
Novum Investigator Site Charlottesville Virginia
Novum Investigator Site Midlothian Virginia
Novum Investigator Site Newport News Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01456611, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 11, 2012 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01456611 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →